FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Börse Stuttgart 14:50:04 2024-06-28 EDT | ||
| 1.88 EUR | +3.30% |
|
| Current month | +8.05% | ||
| 1 month | +16.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 1.88 | +3.30% |
| 24-06-27 | 1.82 | +5.81% |
| 24-06-26 | 1.72 | +0.58% |
| 24-06-25 | 1.71 | -5.00% |
| 24-06-24 | 1.8 | +5.26% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 02:50 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MA3R4M |
| ISIN | DE000MA3R4M4 |
| Date issued | 2020-11-23 |
| Strike | 152.5 $ |
| Maturity | Unlimited |
| Parity | 38.77 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 36.05 € |
|---|---|
| Lowest since issue | 1.11 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8
USD
Average target price
283.2
USD
Spread / Average Target
+22.14%
- Stock Market
- Certificates
- Certificat
